Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Br Dent J ; 236(10): 833-835, 2024 May.
Article in English | MEDLINE | ID: mdl-38789767

ABSTRACT

Before implants are placed, the patient, as part of the consent process, should understand the risks of the treatment but also the importance of a lifelong maintenance programme. This is particularly important if the patient is at risk of periodontitis. There should be arrangements in place for the patient's ongoing care and general dental practitioners who look after the patient need to appreciate their duty of care in monitoring the implants. Excellent record-keeping and valid consent are important factors in delivering care and can also very much help assist a defence in the event of a civil claim or a regulatory investigation.


Subject(s)
Dental Implants , General Practice, Dental , Informed Consent , Humans , General Practice, Dental/legislation & jurisprudence , Informed Consent/legislation & jurisprudence , United Kingdom
2.
J Alzheimers Dis ; 86(1): 343-364, 2022.
Article in English | MEDLINE | ID: mdl-35034897

ABSTRACT

BACKGROUND: The effects of the key pathogens and virulence factors associated with gum disease such as Porphyromonas gingivalis (P. gingivalis) on the central nervous system is of great interest with respect to development of neuropathologies and hence therapeutics and preventative strategies. Chronic infections and associated inflammation are known to weaken the first line of defense for the brain, the blood-brain barrier (BBB). OBJECTIVE: The focus of this study is to utilize an established human in vitro BBB model to evaluate the effects of P. gingivalis virulence factors lipopolysaccharide (LPS) and outer membrane vesicles (OMVs) on a primary-derived human model representing the neurovascular unit of the BBB. METHODS: Changes to the integrity of the BBB after application of P. gingivalis LPS and OMVs were investigated and correlated with transport of LPS. Additionally, the effect of P. gingivalis LPS and OMVs on human brain microvascular endothelial cells in monolayer was evaluated using immunofluorescence microscopy. RESULTS: The integrity of the BBB model was weakened by application of P. gingivalis LPS and OMVs, as measured by a decrease in electrical resistance and a recovery deficit was seen in comparison to the controls. Application of P. gingivalis OMVs to a monoculture of human brain microvascular endothelial cells showed disruption of the tight junction zona occludens protein (ZO-1) compared to controls. CONCLUSION: These findings show that the integrity of tight junctions of the human BBB could be weakened by association with P. gingivalis virulence factors LPS and OMVs containing proteolytic enzymes (gingipains).


Subject(s)
Lipopolysaccharides , Porphyromonas gingivalis , Blood-Brain Barrier/metabolism , Endothelial Cells/metabolism , Humans , Lipopolysaccharides/metabolism , Lipopolysaccharides/pharmacology , Permeability , Tight Junction Proteins/metabolism , Virulence Factors
3.
PLoS Biol ; 18(11): e3000926, 2020 11.
Article in English | MEDLINE | ID: mdl-33232318

ABSTRACT

Devil facial tumour 1 (DFT1) is a transmissible cancer clone endangering the Tasmanian devil. The expansion of DFT1 across Tasmania has been documented, but little is known of its evolutionary history. We analysed genomes of 648 DFT1 tumours collected throughout the disease range between 2003 and 2018. DFT1 diverged early into five clades, three spreading widely and two failing to persist. One clade has replaced others at several sites, and rates of DFT1 coinfection are high. DFT1 gradually accumulates copy number variants (CNVs), and its telomere lengths are short but constant. Recurrent CNVs reveal genes under positive selection, sites of genome instability, and repeated loss of a small derived chromosome. Cultured DFT1 cell lines have increased CNV frequency and undergo highly reproducible convergent evolution. Overall, DFT1 is a remarkably stable lineage whose genome illustrates how cancer cells adapt to diverse environments and persist in a parasitic niche.


Subject(s)
Facial Neoplasms/veterinary , Marsupialia/genetics , Animal Diseases/epidemiology , Animal Diseases/genetics , Animal Diseases/transmission , Animals , DNA Copy Number Variations , Evolution, Molecular , Facial Neoplasms/epidemiology , Facial Neoplasms/genetics , Female , Genomic Instability , Male , Phylogeny , Tasmania/epidemiology , Telomere Shortening/genetics , Tumor Cells, Cultured
4.
Bioorg Chem ; 102: 104070, 2020 09.
Article in English | MEDLINE | ID: mdl-32682157

ABSTRACT

In this study, eighteen heptamethine dyes were synthesised and their antifungal activities were evaluated against three clinically relevant yeast species.. The eighteen dyes were placed within classes based on their core subunit i.e. 2,3,3-trimethylindolenine (5a-f), 1,1,2-trimethyl-1H-benzo[e]indole (6a-f), or 2-methylbenzothiazole (7a-f). The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections. This opens up the opportunity for further optimisation and investigation of this class compounds for potential antifungal treatment.


Subject(s)
Antifungal Agents/therapeutic use , Candida albicans/drug effects , Polyenes/therapeutic use , Antifungal Agents/pharmacology , Humans , Molecular Structure , Polyenes/pharmacology
5.
Bioorg Chem ; 91: 103151, 2019 10.
Article in English | MEDLINE | ID: mdl-31362198

ABSTRACT

The synthesis of a variety of 1,8-substituted anthraquinones, anthrones and bianthrones and their potential as antifungal agents is evaluated. Preliminary screening against Schizosaccharomyces pombe (S. pombe), a fission yeast, and Saccharomyces cerevisiae (S. cerevisiae), a budding yeast, is reported. Both these yeast species demonstrate close homologue to a number of pathogenic fungi.


Subject(s)
Anthracenes/chemistry , Anthraquinones/chemistry , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Mycoses/drug therapy , Saccharomyces cerevisiae/drug effects , Schizosaccharomyces/drug effects , Mycoses/microbiology
6.
Prim Dent J ; 7(3): 24-26, 2018 Sep 01.
Article in English | MEDLINE | ID: mdl-30428963

ABSTRACT

The purpose and intention of this article is to help provide an overview and understanding of the dento-legal issues which can arise when treating patients who are undergoing oral surgery procedures in primary care. The focus will be on the initial stages of assessment, diagnosis and treatment planning, which are essential factors required to appropriately fulfil the requirement of obtaining valid consent. The importance of getting consent right has been highlighted in the context of the Montgomery case and which is further supported by the requirement and importance of accurate and full record keeping in this regard. Examples and appropriate consideration of clinical areas will be discussed with the intention of demonstrating the key points.


Subject(s)
Informed Consent , Oral Surgical Procedures , Risk Management , Humans , Patient Care Planning , Radiography, Dental
7.
J Appl Ecol ; 55(3): 1368-1379, 2018 May.
Article in English | MEDLINE | ID: mdl-30089931

ABSTRACT

1. Monitoring the response of wild mammal populations to threatening processes is fundamental to effective conservation management. This is especially true for infectious diseases, which may have dynamic and therefore unpredictable interactions with their host. 2. We investigate the long-term impact of a transmissible cancer, devil facial tumour disease (DFTD), on the endemic Tasmanian devil. We analyse trends in devil spot-light counts and density across the area impacted by the disease. We investigate the demographic parameters which might be driving these trends, and use spatial capture-recapture models to examine whether DFTD has affected home range size. 3. We found that devils have declined by an average of 77% in areas affected by DFTD, and that there is a congruent trend of ongoing small decline in spotlight counts and density estimates. Despite this, devils have persisted to date within each of nine monitoring sites. One site is showing as yet unexplained small increases in density 8-10 years after the emergence of DFTD. 4. We also found the prevalence of DFTD has not abated despite large declines in density and that diseased sites continue to be dominated by young devils. The long-term impact of the disease has been partially offset by increased fecundity in the form of precocial breeding in 1-year-old females, and more pouch young per female in diseased sites. The lower densities resulting from DFTD did not affect home range size. 5. Synthesis and applications. Transmission of devil facial tumour disease continues despite large declines in devil density over multiple generations. Plasticity in life history traits has ameliorated the impact of devil facial tumour disease, however broad-scale trends in density show ongoing decline. In light of this, devil facial tumour disease and the impact of stochastic events on the reduced densities wrought by the disease, continue to threaten devils. In the absence of methods to manage disease in wild populations, we advocate managing the low population densities resulting from disease rather than disease per se.

8.
Anal Chim Acta ; 1027: 1-8, 2018 Oct 16.
Article in English | MEDLINE | ID: mdl-29866258

ABSTRACT

Monitoring pH within microbial reactors has become an important requirement across a host of applications ranging from the production of functional foods (probiotics) to biofuel cell systems. An inexpensive and scalable composite sensor capable of monitoring the pH within the demanding environments posed by microbial reactors has been developed. A custom designed flavin derivative bearing an electropolymerisable phenol monomer was used to create a redox film sensitive to pH but free from the interferences that can impede conventional pH systems. The film was integrated within a composite carbon-fibre-polymer laminate and was shown to exhibit Nernstian behaviour (55 mV/pH) with minimal drift and robust enough to operate within batch reactors.


Subject(s)
Bioreactors , Biosensing Techniques , Flavins/chemistry , Hydrogen-Ion Concentration , Phenol/chemistry , Batch Cell Culture Techniques , Carbon/chemistry , Carbon Fiber , Electrodes , Enzymes, Immobilized/chemistry , Kefir , Oxidation-Reduction , Platinum/chemistry
10.
Methods Mol Biol ; 1560: 219-229, 2017.
Article in English | MEDLINE | ID: mdl-28155157

ABSTRACT

Determination of cellular neutral lipid levels in yeast is important for both the biotechnology industry and biomedical research. However, many of the currently available methods are labor intensive and time consuming. Here we describe a rapid and repeatable method for the detection of neutral lipids, which can be utilized in both oleaginous and non-oleaginous yeast species. The method utilizes the fluorescent dye, Nile red, which enables neutral lipid levels to either be visualized via microscopy or quantified using a 96-well plate assay.


Subject(s)
Fluorescent Dyes , Lipids , Oxazines , Staining and Labeling , Yeasts/metabolism , Lipids/chemistry , Microscopy, Fluorescence , Staining and Labeling/methods
11.
Physiol Rep ; 4(15)2016 08.
Article in English | MEDLINE | ID: mdl-27511985

ABSTRACT

The currently accepted amount of protein required to achieve maximal stimulation of myofibrillar protein synthesis (MPS) following resistance exercise is 20-25 g. However, the influence of lean body mass (LBM) on the response of MPS to protein ingestion is unclear. Our aim was to assess the influence of LBM, both total and the amount activated during exercise, on the maximal response of MPS to ingestion of 20 or 40 g of whey protein following a bout of whole-body resistance exercise. Resistance-trained males were assigned to a group with lower LBM (≤65 kg; LLBM n = 15) or higher LBM (≥70 kg; HLBM n = 15) and participated in two trials in random order. MPS was measured with the infusion of (13)C6-phenylalanine tracer and collection of muscle biopsies following ingestion of either 20 or 40 g protein during recovery from a single bout of whole-body resistance exercise. A similar response of MPS during exercise recovery was observed between LBM groups following protein ingestion (20 g - LLBM: 0.048 ± 0.018%·h(-1); HLBM: 0.051 ± 0.014%·h(-1); 40 g - LLBM: 0.059 ± 0.021%·h(-1); HLBM: 0.059 ± 0.012%·h(-1)). Overall (groups combined), MPS was stimulated to a greater extent following ingestion of 40 g (0.059 ± 0.020%·h(-1)) compared with 20 g (0.049 ± 0.020%·h(-1); P = 0.005) of protein. Our data indicate that ingestion of 40 g whey protein following whole-body resistance exercise stimulates a greater MPS response than 20 g in young resistance-trained men. However, with the current doses, the total amount of LBM does not seem to influence the response.


Subject(s)
Muscle Proteins/biosynthesis , Myofibrils/metabolism , Whey Proteins/administration & dosage , Adult , Amino Acids/blood , Body Weights and Measures , Exercise , Humans , Male , Muscle, Skeletal/metabolism , Phenylalanine/metabolism , Urea/blood , Young Adult
12.
J Control Release ; 238: 43-57, 2016 09 28.
Article in English | MEDLINE | ID: mdl-27448441

ABSTRACT

A minor population of glioblastoma stem-like cells (GSCs) has been implicated in the relapse and resistance of glioblastoma to therapeutic treatments. Based on knowledge of the involvement of multiple microRNAs in GSC propagation, we designed a combinational approach to target the GSC population with multiple miRNA-based therapeutics. As carriers for the targeted delivery we took advantage of two aptamers that bind to, and inhibit, the receptor tyrosine kinases, Axl and PDGFRß. We showed that the aptamer conjugates are transported through an in vitro blood-brain barrier (BBB) model. Furthermore, combining miR-137 and antimiR-10b synergizes with the receptor inhibitory function of aptamer carriers and prevents GSC expansion. Results highlighted the potential of combining multifunctional RNA-based therapeutics for selective targeting of GSCs and offer a proof of principle strategy to potentially fulfill the still unmet need for effective and safe treatment of glioma.


Subject(s)
Antagomirs/therapeutic use , Aptamers, Nucleotide/therapeutic use , Brain Neoplasms/therapy , Genetic Therapy/methods , Glioma/therapy , MicroRNAs/antagonists & inhibitors , MicroRNAs/therapeutic use , Neoplastic Stem Cells/pathology , Antagomirs/genetics , Aptamers, Nucleotide/metabolism , Brain Neoplasms/genetics , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Line, Tumor , Gene Transfer Techniques , Glioma/genetics , Glioma/metabolism , Glioma/pathology , Humans , MicroRNAs/genetics , Neoplastic Stem Cells/metabolism , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Receptor Protein-Tyrosine Kinases/metabolism , Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors , Receptor, Platelet-Derived Growth Factor beta/metabolism , Axl Receptor Tyrosine Kinase
13.
PLoS One ; 10(8): e0134957, 2015.
Article in English | MEDLINE | ID: mdl-26252900

ABSTRACT

Malignant glioma is characterised by a rapid growth rate and high capacity for invasive infiltration to surrounding brain tissue; hence, diagnosis and treatment is difficult and patient survival is poor. Aptamers contribute a promising and unique technology for the in vitro imaging of live cells and tissues, with a potentially bright future in clinical diagnostics and therapeutics for malignant glioma. The binding selectivity, uptake capacity and binding target of two DNA aptamers, SA43 and SA44, were investigated in glioma cells and patient tissues. The binding assay showed that SA43 and SA44 bound with strong affinity (Kd, 21.56 ± 4.60 nM and Kd, 21.11 ± 3.30 nM respectively) to the target U87MG cells. Quantitative analysis by flow cytometry showed that the aptamers were able to actively internalise in U87MG and 1321N1 glioma cells compared to the non-cancerous and non-glioma cell types. Confocal microscopy confirmed staining in the cytoplasm, and co-localisation studies with endoplasmic reticulum, Golgi apparatus and lysosomal markers suggested internalisation and compartmentalisation within the endomembrane system. Both aptamers selectively bound to Ku 70 and Ku 80 DNA repair proteins as determined by aptoprecipitation (AP) followed by mass spectrometry analysis and confirmation by Western blot. In addition, aptohistochemical (AHC) staining on paraffin embedded, formalin fixed patient tissues revealed that the binding selectivity was significantly higher for SA43 aptamer in glioma tissues (grade I, II, III and IV) compared to the non-cancerous tissues, whereas SA44 did not show selectivity towards glioma tissues. The results indicate that SA43 aptamer can differentiate between glioma and non-cancerous cells and tissues and therefore, shows promise for histological diagnosis of glioma.


Subject(s)
Aptamers, Nucleotide/metabolism , Brain Neoplasms/metabolism , Glioma/metabolism , Aptamers, Nucleotide/chemistry , Biotinylation , Brain Neoplasms/pathology , Cell Line, Tumor , Cell Survival , Chemical Precipitation , Flow Cytometry , Glioma/pathology , Humans , Immunohistochemistry , Microscopy, Confocal , Neoplasm Proteins/metabolism , Nucleic Acid Conformation , Subcellular Fractions/metabolism , Temperature
14.
Antonie Van Leeuwenhoek ; 108(1): 97-106, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25948336

ABSTRACT

Investigation of yeast neutral lipid accumulation is important for biotechnology and also for modelling aberrant lipid metabolism in human disease. The Nile red (NR) method has been extensively utilised to determine lipid phenotypes of yeast cells via microscopic means. NR assays have been used to differentiate lipid accumulation and relative amounts of lipid in oleaginous species but have not been thoroughly validated for phenotype determination arising from genetic modification. A modified NR assay, first described by Sitepu et al. (J Microbiol Methods 91:321-328, 2012), was able to detect neutral lipid changes in Saccharomyces cerevisiae deletion mutants with sensitivity similar to more advanced methodology. We have also be able to, for the first time, successfully apply the NR assay to the well characterised fission yeast Schizosaccharomyces pombe, an increasingly important organism in biotechnology. The described NR fluorescence assay is suitable for increased throughput and rapid screening of genetically modified strains in both the biotechnology industry and for modelling ectopic lipid production for a variety of human diseases. This ultimately negates the need for labour intensive and time consuming lipid analyses of samples that may not yield a desirable lipid phenotype, whilst genetic modifications impacting significantly on the cellular lipid phenotype can be further promoted for more in depth analyses.


Subject(s)
Lipids/analysis , Oxazines/metabolism , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae/classification , Schizosaccharomyces/chemistry , Schizosaccharomyces/classification , Staining and Labeling/methods , Fluorescence , Lipid Metabolism , Mass Screening/methods , Phenotype , Saccharomyces cerevisiae/metabolism , Schizosaccharomyces/metabolism
15.
Eur J Med Chem ; 64: 222-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23644205

ABSTRACT

The synthesis of a variety of N-alkylated 2,3,3-trimethylindolenines and 2-methylbenzothiazoles is reported herein. Their potential as antifungal agents is evaluated by preliminary screening against Saccharomyces cerevisiae (S. cerevisiae), Schizosaccharomyces pombe (S. pombe), and Candida albicans (C. albicans). Statistical analyses illustrate a strong relationship between chain length and growth inhibition for S. cerevisiae and S. pombe (p < 0.0001 in every case). Of particular interest is the activity of both sets of compounds against S. cerevisiae, as this is emerging as an opportunistic pathogen, especially in immunosuppressed and immunocompromised patients. Bioassays were set up to compare the efficacy of our range of N-alkylated compounds against classic antifungal agents; Amphotericin B and Thiabendazole.


Subject(s)
Antifungal Agents/pharmacology , Benzothiazoles/pharmacology , Candida albicans/drug effects , Indoles/pharmacology , Saccharomyces cerevisiae/drug effects , Schizosaccharomyces/drug effects , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Benzothiazoles/chemical synthesis , Benzothiazoles/chemistry , Candida albicans/growth & development , Dose-Response Relationship, Drug , Indoles/chemical synthesis , Indoles/chemistry , Microbial Sensitivity Tests , Molecular Structure , Saccharomyces cerevisiae/growth & development , Schizosaccharomyces/growth & development , Structure-Activity Relationship
16.
Curr Biol ; 19(22): 1907-11, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19836238

ABSTRACT

The Atf1 transcription factor is critical for directing stress-induced gene expression in fission yeast [1]. Upon exposure to stress, Atf1 is hyperphosphorylated by the mitogen-activated protein kinase (MAPK) Sty1 [2, 3], which results in its stabilization [4]. The resulting increase in Atf1 is vital for a robust response to certain stresses [4]. Here we investigated the mechanism by which phosphorylation stabilizes Atf1. We show that Atf1 is a target for the ubiquitin-proteasome system and that its degradation is dependent upon an SCF E3 ligase containing the F box protein Fbh1. Turnover of Atf1 requires an intact F box, but not DNA helicase activity of Fbh1. Accordingly, disruption of Fbh1 F box function suppresses phenotypes associated with loss of Atf1 phosphorylation. Atf1 and Fbh1 interact under basal conditions, but this binding is lost upon stress. In contrast, a version of Atf1 lacking all intact MAPK sites still interacts with Fbh1 upon stress, indicating that the association between the F box protein and substrate is disrupted by stress-induced phosphorylation. Most F box protein-substrate interactions described to date are mediated positively by phosphorylation [5]. Thus, our findings represent a novel means of regulating the interaction between an F box protein and its substrate. Moreover, Atf1 is the first target described in any organism for the Fbh1 F box protein.


Subject(s)
Activating Transcription Factor 1/metabolism , DNA Helicases/metabolism , Phosphoproteins/metabolism , Schizosaccharomyces pombe Proteins/metabolism , Schizosaccharomyces/metabolism , Stress, Physiological , Phosphorylation , Protein Binding
17.
J Biol Chem ; 283(15): 9945-56, 2008 Apr 11.
Article in English | MEDLINE | ID: mdl-18252721

ABSTRACT

The stress-induced expression of many fission yeast genes is dependent upon the Sty1 mitogen-activated protein kinase (MAPK) and Atf1 transcription factor. Atf1 is phosphorylated by Sty1 yet this phosphorylation is not required for stress-induced gene expression, suggesting another mechanism exists whereby Sty1 activates transcription. Here we show that Sty1 associates with Atf1-dependent genes and is recruited to both their promoters and coding regions. This occurs in response to various stress conditions coincident with the kinetics of the activation of Sty1. Association with promoters is not a consequence of increased nuclear accumulation of Sty1 nor does it require the phosphorylation of Atf1. However, recruitment is completely abolished in a mutant lacking Sty1 kinase activity. Both Atf1 and its binding partner Pcr1 are required for association of Sty1 with Atf1-dependent promoters, suggesting that this heterodimer must be intact for optimal recruitment of the MAPK. However, many Atf1-dependent genes are still expressed in a pcr1Delta mutant but with significantly delayed kinetics, thus providing an explanation for the relatively mild stress sensitivity displayed by pcr1Delta. Consistent with this delay, Sty1 and Atf1 cannot be detected at these promoters in this condition, suggesting that their association with chromatin is weak or transient in the absence of Pcr1.


Subject(s)
Activating Transcription Factor 1/metabolism , Activating Transcription Factors/metabolism , Cell Nucleus/metabolism , Gene Expression Regulation, Fungal/physiology , Mitogen-Activated Protein Kinases/metabolism , Phosphoproteins/metabolism , Schizosaccharomyces pombe Proteins/metabolism , Schizosaccharomyces/metabolism , Activating Transcription Factor 1/genetics , Activating Transcription Factors/genetics , Active Transport, Cell Nucleus/physiology , Cell Nucleus/genetics , Chromatin/genetics , Chromatin/metabolism , Gene Deletion , Mitogen-Activated Protein Kinases/genetics , Open Reading Frames/physiology , Phosphoproteins/genetics , Phosphorylation , Promoter Regions, Genetic/physiology , Schizosaccharomyces/genetics , Schizosaccharomyces pombe Proteins/genetics
18.
J Cell Biol ; 177(6): 981-93, 2007 Jun 18.
Article in English | MEDLINE | ID: mdl-17562791

ABSTRACT

Spindle elongation in anaphase of mitosis is a cell cycle-regulated process that requires coordination between polymerization, cross-linking, and sliding of microtubules (MTs). Proteins that assemble at the spindle midzone may be important for this process. In this study, we show that Ase1 and the separase-Slk19 complex drive midzone assembly in yeast. Whereas the conserved MT-bundling protein Ase1 establishes a midzone, separase-Slk19 is required to focus and center midzone components. An important step leading to spindle midzone assembly is the dephosphorylation of Ase1 by the protein phosphatase Cdc14 at the beginning of anaphase. Failure to dephosphorylate Ase1 delocalizes midzone proteins and delays the second, slower phase of anaphase B. In contrast, in cells expressing nonphosphorylated Ase1, anaphase spindle extension is faster, and spindles frequently break. Cdc14 also controls the separase-Slk19 complex indirectly via the Aurora B kinase. Thus, Cdc14 regulates spindle midzone assembly and function directly through Ase1 and indirectly via the separase-Slk19 complex.


Subject(s)
Anaphase , Phosphoprotein Phosphatases/metabolism , Schizosaccharomyces pombe Proteins/metabolism , Cell Cycle Proteins/physiology , Endopeptidases/physiology , Microtubule-Associated Proteins , Multiprotein Complexes , Phosphoprotein Phosphatases/physiology , Phosphorylation , Schizosaccharomyces , Schizosaccharomyces pombe Proteins/physiology , Separase , Spindle Apparatus
19.
J Biol Chem ; 282(8): 5160-70, 2007 Feb 23.
Article in English | MEDLINE | ID: mdl-17182615

ABSTRACT

The Atf1 transcription factor plays a vital role in the ability of Schizosaccharomyces pombe cells to respond to various stress conditions. It regulates the expression of many genes in a stress-dependent manner, and its function is dependent upon the stress-activated MAPK, Sty1/Spc1. Moreover, Atf1 is directly phosphorylated by Sty1. Here we have investigated the role of such phosphorylation. Atf1 protein accumulates following stress, and this accumulation is lost in a strain defective in the Sty1 signaling pathway. In addition, accumulation of a mutant Atf1 protein that can no longer be phosphorylated is lost. Measurement of the half-life of Atf1 demonstrates that changes in Atf1 stability are responsible for this accumulation. Atf1 stability is also regulated by its heterodimeric partner, Pcr1. Similarly, Pcr1 levels are regulated by Atf1. Thus multiple pathways exist that ensure that Atf1 levels are appropriately regulated. Phosphorylation of Atf1 is important for cells to mount a robust response to H(2)O(2) stress, because the Atf1 phospho-mutant displays sensitivity to this stress, and induction of gene expression is lower than that observed in wild-type cells. Surprisingly, however, loss of Atf1 phosphorylation does not lead to the complete loss of stress-activated expression of Atf1 target genes. Accordingly, the Atf1 phospho-mutant does not display the same overall stress sensitivities as the atf1 deletion mutant. Taken together, these data suggest that Sty1 phosphorylation of Atf1 is not required for activation of Atf1 per se but rather for modulating its stability.


Subject(s)
Activating Transcription Factor 1/metabolism , Activating Transcription Factors/metabolism , MAP Kinase Signaling System , Mitogen-Activated Protein Kinases/metabolism , Phosphoproteins/metabolism , Protein Processing, Post-Translational , Schizosaccharomyces pombe Proteins/metabolism , Schizosaccharomyces/metabolism , Activating Transcription Factor 1/genetics , Activating Transcription Factors/genetics , Dimerization , Gene Expression Regulation, Fungal/drug effects , Gene Expression Regulation, Fungal/genetics , Hydrogen Peroxide/pharmacology , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/genetics , Mitogen-Activated Protein Kinases/genetics , Osmotic Pressure/drug effects , Oxidants/pharmacology , Phosphoproteins/genetics , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , Protein Processing, Post-Translational/genetics , Schizosaccharomyces/genetics , Schizosaccharomyces pombe Proteins/genetics , Sequence Deletion , Sorbitol/pharmacology , Sweetening Agents/pharmacology
20.
J Immunol ; 177(6): 3827-36, 2006 Sep 15.
Article in English | MEDLINE | ID: mdl-16951345

ABSTRACT

The cathepsin B inhibitor, benzyloxycarbonyl-phenyl-alanyl-fluoromethylketone (z-FA-FMK) at nontoxic doses was found to be immunosuppressive and repressed human T cell proliferation induced by mitogens and IL-2 in vitro. We showed that z-FA-FMK suppresses the secretion of IL-2 and IFN-gamma as well as the expression of IL-2R alpha-chain (CD25) in activated T cells, whereas the expression of the early activated T cell marker, CD69, was unaffected. Furthermore, z-FA-FMK blocks NF-kappaB activation, inhibits T cell blast formation, and prevents cells from entering and leaving the cell cycle. z-FA-FMK inhibits the processing of caspase-8 and caspase-3 to their respective subunits in resting T cells stimulated through the Ag receptor, but has no effect on the activation of these caspases during Fas-induced apoptosis in proliferating T cells. When administered in vivo, z-FA-FMK significantly increased pneumococcal growth in both lungs and blood, compared with controls, in a mouse model of intranasal pneumococcal infection. Because host response to bronchopneumonia in mice is T cell dependent, our collective results demonstrated that z-FA-FMK is immunosuppressive in vitro and in vivo.


Subject(s)
Cathepsin B/antagonists & inhibitors , Cell Proliferation/drug effects , Cysteine Proteinase Inhibitors/pharmacology , Dipeptides/pharmacology , Immunosuppressive Agents/pharmacology , Ketones/pharmacology , Pneumococcal Infections/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/enzymology , Animals , Apoptosis/drug effects , Apoptosis/immunology , Cells, Cultured , Dipeptides/administration & dosage , Female , Growth Inhibitors/pharmacology , Humans , Immunosuppressive Agents/administration & dosage , Ketones/administration & dosage , Mice , Pneumococcal Infections/enzymology , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/growth & development , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...